Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4Myasthenia Gravis 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Prolymphocytic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1Leukemia 1

Interventions

liposomal amphotericin B 2Early Intervention, Educational 2Darbepoetin alfa 2fludarabine phosphate 1ferrous sulfate 1ferric gluconate 1Whole-Body Irradiation 1Sucrose 1Sirolimus 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Ondansetron 1Mycophenolic Acid 1Morphine 1Levofloxacin 1Ketamine 1Fentanyl 1Epoetin Alfa 1Dextromethorphan 1Dalteparin 1Cyclosporins 1Cyclosporine 1Cladribine 1Cefepime 1Caspofungin 1Asian ginseng 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Prolymphocytic × Cladribine × Clear all
NCT00003746 2012-05-15

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Swiss Cancer Institute

Phase 3 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡